SCHEMBL6498560

SCHEMBL6498560

CCN(CCNC(=O)c1ccc(F)cc1)Cc1cccc(Oc2ccccc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
MCHR1 Q99705 3/20 0.59
POLB P06746 1/20 0.54
OPRM1 P35372 5/20 0.52
OPRK1 P41145 5/20 0.52
ACKR3 P25106 1/20 0.52
TMEM97 Q5BJF2 1/20 0.52
SIGMAR1 Q99720 1/20 0.52
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MAPK14 Q16539 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
FFAR1 O14842 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CCNT1 O60563 1/20 0.46
CCNA2 P20248 1/20 0.46
CDK2 P24941 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499869 0.94 ACKR3 (0.58) MEN1KMT2AMCHR1POLBACKR3
SCHEMBL6503729 0.87 EPHX2 (0.58) MEN1KMT2AMCHR1RAB9ATSHR
SCHEMBL6503460 0.85 SIGMAR1 (0.52) OPRM1OPRK1ACKR3TMEM97SIGMAR1
SCHEMBL6505559 0.81 EPHX2 (0.56) KMT2AACKR3RAB9ATSHRHSD17B10
SCHEMBL6500610 0.80 GAA (0.59) MEN1KMT2ATSHRHSD17B10FFAR1
SCHEMBL6505391 0.80 TSHR (0.52) MEN1KMT2AMCHR1TSHRHSD17B10
SCHEMBL6499688 0.80 CYP1A2 (0.56) MEN1KMT2ARAB9ATSHRHSD17B10
SCHEMBL6508701 0.78 KDM4E (0.50) MEN1KMT2ATSHRHSD17B10
SCHEMBL12438386 0.77 POLB (0.84) MCHR1POLBTMEM97SIGMAR1TSHR
SCHEMBL9363810 0.77 POLB (0.84) MCHR1POLBTMEM97SIGMAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143372-A1 Compounds, pharmaceutical compositions and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143372-A1 Compounds, pharmaceutical compositions and methods of use therefor CCR8, CCL11, CCR5 MEN1 3088/4885KMT2A 4477/4885MCHR1 453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.